Indoco Remedies Limited, established in 1947, is a Mumbai-based pharmaceutical company specializing in formulations and active pharmaceutical ingredients (APIs), with a global presence in 55 countries. With a revenue of USD 166 million, the company employs over 6,000 staff, including 300 skilled scientists, across 9 manufacturing facilities and a state-of-the-art R&D center. Indoco focuses on various therapeutic segments such as anti-infective, ophthalmic, and anti-inflammatory, and has expanded into diabetic and cardiovascular segments.
The company has been recognized for its R&D efforts, receiving patents and awards for its innovative processes. Indoco's strategic acquisitions, such as Xtend Industrial Designers and Engineers Pvt. Ltd. and a clinical research division from Piramal Enterprises, enhance its research capabilities and reduce dependency on outsourcing. To support its international ambitions, Indoco has subsidiaries in the Czech Republic, UK, and previously in Singapore, facilitating expansion in European and US markets. The company's robust marketing network and strategic focus on the prescription segment have driven its growth and market presence.
